2013
DOI: 10.1016/s0016-5085(13)60072-4
|View full text |Cite
|
Sign up to set email alerts
|

92 Adalimumab Is More Effective Than Azathioprine and Mesalamine At Preventing Postoperative Recurrence of Crohn's Disease - A Randomized Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
43
0
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(47 citation statements)
references
References 0 publications
3
43
0
1
Order By: Relevance
“…A total of 32 articles were excluded based on the full text article (Supplementary Figure 1), 6 of them because there was no control arm. The 9 controlled trials that fulfilled the inclusion criteria were included in the meta-analysis [5][6][7][8]11,13,[20][21][22].…”
Section: Literature Searchmentioning
confidence: 99%
See 2 more Smart Citations
“…A total of 32 articles were excluded based on the full text article (Supplementary Figure 1), 6 of them because there was no control arm. The 9 controlled trials that fulfilled the inclusion criteria were included in the meta-analysis [5][6][7][8]11,13,[20][21][22].…”
Section: Literature Searchmentioning
confidence: 99%
“…Among these, 7 separate studies reported the efficacy of anti-TNF␣ in preventing postoperative recurrence of CD, and 2 studies reported the efficacy of anti-TNF␣ in treating the postoperative recurrence of CD. Four trials out of nine (5)(6)(7)(8) were of high quality (Jadad score ≥ 3 points).…”
Section: Literature Searchmentioning
confidence: 99%
See 1 more Smart Citation
“…3), we concluded that ADA was quite effective for this case. In addition, Savarino et al reported that administration of ADA after intestinal resective surgery was effective in preventing the endoscopic and clinical recurrence of CD [9]. In addition, it is not uncommon for patients to have a good response to biologics after removal of CD lesions.…”
Section: Discussionmentioning
confidence: 99%
“…Eine Prophylaxe mit Anti-TNF-Antikörpern ist nach bisher veröffentlichten, kleinen Studien eine effektive Strategie [7,20,29]. Eine aktuell noch laufende Studie versucht dies für eine größere Hochrisikopopulation nachzuvollziehen (NCT01190839).…”
Section: Morbus Crohnunclassified